Robert Alexander Ingram

BDTX 5,000 shares
NOVN 169,777 shares
BCRX 28,088 shares

The estimated Net Worth of Robert Alexander Ingram is at least $611,475.29. Robert Alexander Ingram owns over 5,000 units of Black Diamond Therapeutics, Inc. stock worth over $152,285.00.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
30th September 2020BDTX - Black Diamond Therapeutics, Inc.5,000Open or private purchase5,000$30.46$152,285.00$152,285.00
22nd May 2019NOVN - Novan, Inc.50,000Open or private purchase169,777$2.21$110,500.00$375,207.17
1st September 2019BCRX - BioCryst Pharmaceuticals, Inc.6,270Grant/award etc.28,088$2.99$18,747.30$83,983.12
18th November 2019BCRX - BioCryst Pharmaceuticals, Inc.20,000Open or private purchase48,088$1.45$29,000.00$69,727.60
1st December 2019BCRX - BioCryst Pharmaceuticals, Inc.6,578Grant/award etc.54,666$2.85$18,747.30$155,798.10
1st March 2020BCRX - BioCryst Pharmaceuticals, Inc.6,250Grant/award etc.60,916$3.00$18,750.00$182,748.00
1st June 2020BCRX - BioCryst Pharmaceuticals, Inc.4,171Grant/award etc.65,087$4.50$18,748.65$292,566.07
31st August 2020BCRX - BioCryst Pharmaceuticals, Inc.4,518Grant/award etc.69,605$4.15$18,749.70$288,860.75